Evidence map›Paper›PMID 33471323›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Morphogenic Regulators and Their Application in Improving Plant Transformation.

Samson Nalapalli, Meral Tunc-Ozdemir, Yuejin Sun, Sivamani Elumalai, Qiudeng Que

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Plants (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Genotype-independent plant transformation.Horticulture research · 2022
    Article
  10. Hemp Genome Editing-Challenges and Opportunities.Frontiers in genome editing · 2022
    Review
  11. Establishment of a Novel and EfficientPlants (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Samson NalapalliSeeds Research, Syngenta Crop Protection LLC, Research Triangle Park, NC, USA. sam.nalapalli@syngenta.com.
Meral Tunc-OzdemirMetabolon, Inc., Morrisville, NC, USA.
Yuejin SunSeeds Research, Syngenta Crop Protection LLC, Research Triangle Park, NC, USA.
Sivamani ElumalaiSeeds Research, Syngenta Crop Protection LLC, Research Triangle Park, NC, USA.
Qiudeng QueSeeds Research, Syngenta Crop Protection LLC, Research Triangle Park, NC, USA.
Syngenta (United States) · USMetabolon (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generation of plant lines with transgene or edited gene variants is the desired outcome of transformation technology. Conventional DNA-based plant transformation methods are the most commonly used technology but these approaches are limited to a small number of plant species with efficient transformation systems. The ideal transformation technologies are those that allow biotechnology applications across wide genetic background, especially within elite germplasm of major crop species. This chapter will briefly review key regulatory genes involved in plant morphogenesis with a focus on in vitro somatic embryogenesis and their application in improving plant transformation.

Indexed as

Plant DevelopmentTransformation, GeneticBiotechnologyCrops, AgriculturalGenetic VectorsPlant ProteinsPlants, Genetically ModifiedPlant Somatic Embryogenesis TechniquesPlant ProteinsApical meristemMorphogenic genesMorphogenic regulatorsPlant morphogenesisPlant transformationSomatic embryogenesisTotipotency

Identifiers

PMID33471323
OpenAlexW3122336061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.